Lightwork

APRIL 24, 2025

Depression treatment has evolved beyond the traditional approach of prescribing antidepressants like Lexapro and Wellbutrin. While these medications play a crucial role in managing depression, they’re just one piece of the treatment puzzle. Conclusion Depression treatment isn’t the same for everyone.

Neurotransmitters and mental health

Bullet Psych

OCTOBER 7, 2022

Pharmacotherapy : Fluoxetine is the only FDA approved medication for the treatment of bulimia nervosa (in adults) and should be considered as the first-line medication option. The effective dose is typically higher than average depression treatment (60-80 mg/day). Other SSRIs (e.g.

Eating disorders

Bullet Psych

JANUARY 22, 2023

Fluoxetine is FDA approved for the treatment of bulimia nervosa (in adults) which has been shown to reduce frequency of binge eating, however it is technically an off-label use for BED. The effective dose is typically higher than average depression treatment (60-80 mg/day). Other SSRIs (e.g.

Eating disorders

Lightwork

MAY 8, 2025

Our outpatient program offers flexible and effective treatment options. In this article, we’ll explore how effective CBT is in treating various women’s mental health conditions, supported by research and clinical experience.

Cognitive Behavioral Therapy

Mad in America

DECEMBER 31, 2024

Searching for the Psychiatric Yeti: Schizophrenia Is Not Genetic In January, Peter Simons wrote that the decades-long attempt to locate the gene or genes for schizophrenia has failed, according to a new article in Psychiatric Research by prominent schizophrenia researcher E. In it, he examines the concept of treatment-resistant depression.

Genetics and mental health

Mad in America

APRIL 27, 2024

This was a story of a great medical advance, and the announced results from the STAR*D trial, heralded by the NIMH as the “largest and longest study ever done to evaluate depression treatment,” fit into that story of medical progress, for it told of 70% of depressed patients becoming “symptom free” after repeated treatments with antidepressants.

Self-awareness

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder

Mad in America

JUNE 20, 2024

The Fix is Broken An article about “Treatment resistant depression,” ought to define treatment resistant depression. Hundreds of articles are devoted to defining it, observing that it is yet to be defined or saying we should really get on top of defining it. billion worldwide.

Pharmaceuticals

My Psychiatry

JANUARY 14, 2025

Whenever these symptoms persist beyond two weeks or intensify, the condition is referred to as postpartum depression. In this article, we will focus on explaining why postpartum depression occurs, signs and symptoms, and how to seek professional help. What Is Postpartum Depression?

Sleep and mental health

Mad in America

SEPTEMBER 18, 2024

The first NIMH treatment outcome study , which was published in 1989, found the drug treatment (imipramine) to be no more effective than placebo when measures were taken after three months of treatment. The NIH article also repeats another of STAR*D’s drug-related falsehoods.

Aging and mental health